Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy

Clinical Trials, Metastatic Castration Resistant Prostate Cancer (MCRPC), Metastatic Castration Sensitive Prostate Cancer (MCSPC)

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT05919329
Phase: PHASE4
Trial Summary: This clinical trial investigates the change in prostate-specific membrane antigen (PSMA) expression in response to hormonal therapy in both, Castration Sensitive Prostate Cancer (CSPC) and Castration – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): OHSU Knight Cancer Institute
Acronym:

Pin It on Pinterest